---
title: Real-world multicentre cohort study on choices and effectiveness of immunotherapies
  in NMOSD and MOGAD
date: '2024-12-27'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39730197/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241228170645&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: This study provides insights into the evolving treatment
  landscape and effectiveness of immunotherapies in NMOSD and MOGAD. Established off-label
  therapies continue to play an important role, especially for patients with stable
  disease, with emerging evidence supporting newly approved therapies. Future studies
  are needed to refine treatment algorithms and address the ongoing uncertainties
  in MOGAD ...'
disable_comments: true
---
CONCLUSIONS: This study provides insights into the evolving treatment landscape and effectiveness of immunotherapies in NMOSD and MOGAD. Established off-label therapies continue to play an important role, especially for patients with stable disease, with emerging evidence supporting newly approved therapies. Future studies are needed to refine treatment algorithms and address the ongoing uncertainties in MOGAD ...